Siren, L.L.C. Novo Cure LTD Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
A detailed history of Siren, L.L.C. transactions in Novo Cure LTD stock. As of the latest transaction made, Siren, L.L.C. holds 350,884 shares of NVCR stock, worth $6.28 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
350,884Holding current value
$6.28 Million% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
267Shares Held
79MCall Options Held
737KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$217 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$212 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$142 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$77.1 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$54.2 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.88B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...